Cargando…

Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study

The outcomes for patients with esophageal cancer (EC) underwent standard-dose radical radiotherapy were still disappointing. This phase II study investigated the feasibility, safety and efficacy of radiation dose escalation using simultaneous modulated accelerated radiotherapy (SMART) combined with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jianzhou, Guo, Hong, Zhai, Tiantian, Chang, Daniel, Chen, Zhijian, Huang, Ruihong, Zhang, Wuzhe, Lin, Kun, Guo, Longjia, Zhou, Mingzhen, Li, Dongsheng, Li, Derui, Chen, Chuangzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008394/ https://www.ncbi.nlm.nih.gov/pubmed/26992206 http://dx.doi.org/10.18632/oncotarget.8050

Ejemplares similares

Distribution of Peripheral Blood Cells in Esophageal Cancer Patients During Concurrent Chemoradiotherapy Predicts Long-Term Locoregional Progression Hazard After Treatment (GASTO1072)
por: Xu, Liangyu, et al.
Publicado: (2021)

Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal Carcinoma
por: Huang, Ruihong, et al.
Publicado: (2020)

Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study
por: Chen, Chuangzhen, et al.
Publicado: (2021)

Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy
por: Zeng, Chengbing, et al.
Publicado: (2021)

A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072)
por: Liu, Weitong, et al.
Publicado: (2022)

Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089)
por: Peng, Guobo, et al.
Publicado: (2022)

Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer
por: Huang, Bao-Tian, et al.
Publicado: (2017)

A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly
por: Guo, SuPing, et al.
Publicado: (2021)

Dosimetric Comparison and Evaluation of Three Radiotherapy Techniques for Use after Modified Radical Mastectomy for Locally Advanced Left-sided Breast Cancer
por: Ma, Changchun, et al.
Publicado: (2015)

Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
por: Zhang, Wei, et al.
Publicado: (2018)

Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams
por: Zhuang, Mingzan, et al.
Publicado: (2013)

A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer
por: Li, Chen, et al.
Publicado: (2019)

Tracheoesophageal fistula closure after staged dose-escalated radiotherapy for esophageal squamous cell carcinoma: a case report
por: Zhen, Chan-jun, et al.
Publicado: (2023)

XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients
por: Li, Haijun, et al.
Publicado: (2013)

Volumetric modulation arc radiotherapy with flattening filter-free beams compared with conventional beams for nasopharyngeal carcinoma: a feasibility study
por: Zhuang, Mingzan, et al.
Publicado: (2013)

Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas
por: Tang, Jian Min, et al.
Publicado: (2014)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

De-escalating chemotherapy for stage II colon cancer?
por: Fu, Jianfei, et al.
Publicado: (2019)

Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation?
por: Socha, Joanna, et al.
Publicado: (2023)

Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03)
por: Zhang, Wencheng, et al.
Publicado: (2020)

PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p
por: Zhang, Ying, et al.
Publicado: (2022)

Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma
por: Fareed, Muhammad M, et al.
Publicado: (2013)

Dose calculation of Acuros XB and Anisotropic Analytical Algorithm in lung stereotactic body radiotherapy treatment with flattening filter free beams and the potential role of calculation grid size
por: Huang, Baotian, et al.
Publicado: (2015)

Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer
por: Fan, Chao-Yueh, et al.
Publicado: (2018)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”
por: Chow, Ronald, et al.
Publicado: (2021)

Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial
por: Lin, Qiang, et al.
Publicado: (2013)

Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis
por: Xie, Renxian, et al.
Publicado: (2023)

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose‐escalation feasibility study
por: Cilla, Savino, et al.
Publicado: (2018)

Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
por: Jo, Sunmi, et al.
Publicado: (2016)

Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance
por: Ma, Jin-lu, et al.
Publicado: (2014)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Impact of chemotherapy and radiotherapy on the survival of elderly esophageal cancer patients undergoing surgery: a SEER database analysis
por: Li, Xinrong, et al.
Publicado: (2021)

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.
por: Saunders, M. I., et al.
Publicado: (1998)

An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy
por: Ma, Li, et al.
Publicado: (2018)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
por: Kim, Hyung Jin, et al.
Publicado: (2016)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study
por: Wang, Dongqing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5flrdtn8fog5k10gi39vjb3gfd